№ files_lp_3_process_7_013444
This document outlines the guidelines for adverse event reporting for outsourcing facilities under section 503B of the Federal Food, Drug, and Cosmetic Act.
Year: 2015
Region / City: United States
Topic: Adverse Event Reporting, Drug Compounding, Outsourcing Facilities
Document Type: Guidance
Organization: U.S. Department of Health and Human Services, Food and Drug Administration
Author: U.S. Food and Drug Administration
Target Audience: Outsourcing facilities registered under section 503B of the Federal Food, Drug, and Cosmetic Act
Period of Validity: Ongoing
Approval Date: November 27, 2013
Revision Date: June 10, 2015
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.